Dyve Biosciences, in collaboration with Moffitt Cancer Center, today reported significant study results for a first-of-its-kind investigational therapy applied to the skin and des ...

Real world treatment practices and outcomes of metastatic Merkel cell carcinoma: A retrospective study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...

A new study has identified a molecular guardian that keeps skin cells from forgetting what they are and transforming into aggressive, migratory killers. By stabilizing a master genetic switch, this ...

Malignant cutaneous melanoma is the most invasive and metastatic type of skin cancer. Surgical resection, the conventional ...

The tumor microbiota—which includes bacteria, fungi, viruses, and other microorganisms present in tumor tissue—is now ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Existing oncology therapeutics are either so specific they can target only part of a tumor, or so generalized they kill healthy tissue. A new “Tumor Activated Therapy™” in development at the small ...

Johns Hopkins University cancer researcher Mikala Egeblad has received the 2025 Ernst W. Bertner Memorial Award in recognition of her research into how tumor microenvironments impact cancer ...

The inflammatory tumor microenvironment (TME) is a complex network of cancer, immune, and stromal cells interacting through cytokines and growth factors to drive tumor growth, angiogenesis, and immune ...

Researchers are launching a new project to crack the mystery of aggressive breast cancer, where predicting disease ...

A protein that helps cancer cells hide from the immune system may have a critical weakness, according to research that could ...